As of 2025, Chugai Pharmaceutical has disclosed 8 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 8 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Chugai Pharmaceutical's climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -40%a | 2025 |
Absolute-based Target* | Scope 1 - Process | Metric Tonnes of CO2 equivalent (mtCO2e) | -25%a | 2025 |
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -50%a | 2027 |
Absolute-based Target* | Scope 1 - Process | Metric Tonnes of CO2 equivalent (mtCO2e) | -35%a | 2027 |
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -60%a | 2030 |
Absolute-based Target* | Scope 1 - Process | Metric Tonnes of CO2 equivalent (mtCO2e) | -100%a | 2030 |
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -30%a | 2030 |
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -100%a | 2050 |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
As of 2025, Chugai Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.a
As of 2025, Chugai Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a
Chugai Pharmaceutical's most ambitious operational target is to reduce these emissions by 100% by 2050, compared to a baseline of 112,800 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019.a
As of 2025, Chugai Pharmaceutical is ahead of schedule on its operational emissions reduction target, having achieved 55.77% of the planned reduction.a
As of 2025, Chugai Pharmaceutical has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol.a
Chugai Pharmaceutical's most ambitious value chain target is to reduce these emissions by 30% by 2030, compared to a baseline of 967,000 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019.a
Instead of reducing value chain emissions, Chugai Pharmaceutical has increased them, with 2025 levels exceeding those of the 2019 baseline, placing the company well behind its reduction target.a